What You Should Know:
– Cedars-Sinai Intellectual Property Company and Oxford Science Enterprises (OSE) have announced a strategic partnership to co-invest in and support the development of digital health startups.
– To kick off the partnership, Cedars-Sinai and OSE have co-invested $2 million in Neu Health, a University of Oxford spin-out company that has developed a digital neurology care platform. Neu Health’s platform uses a smartphone app and AI to track and analyze patient symptoms, providing clinicians with objective, actionable information to improve care for individuals with Parkinson’s disease and dementia.
– As part of the co-investment, Neu Health will pilot its digital platform at Cedars-Sinai, marking its entry into the United States market.
